Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Pregnancy Increases Mental Health Risk in MS Patients
THURSDAY, Jan. 23, 2025 -- Pregnancy increases the risk of mental illness among women with multiple sclerosis (MS).Pregnant MS patients have a higher risk of...
Controlling Infections Might Lower Dementia Risk
THURSDAY, Jan. 23, 2025 -- Preventing or treating infections could be a key means of warding off dementia, a new evidence review says.Vaccines, antibiotics...
Fitter Folks Have Better Odds Against Cancer
THURSDAY, Jan. 23, 2025 -- Pumping iron and hitting the treadmill can improve your odds against cancer, a new evidence review says.People with more muscle...
Fatty Muscles Increase Heart Disease Risk
THURSDAY, Jan. 23, 2025 -- A well-marbled steak is highly prized for grilling, but those sort of fat deposits in human muscles can be deadly, a new study...
Nutrition Labels Only Slightly Effective in Cutting Calories
THURSDAY, Jan. 23, 2025 -- It's easy these days to see how many calories a cheeseburger will set you back, or how many added sugars are in a jar of pasta...
FDA Approves Grafapex (treosulfan) Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation
On January 22, 2025, Medexus was informed that the FDA approved Grafapex, an alkylating agent, with fludarabine as a preparative regimen for allogeneic...
Trump Issues Executive Order Withdrawing U.S. From WHO
WEDNESDAY, Jan. 22, 2025 -- In one of his first presidential actions on Monday, President Trump issued an executive order withdrawing the United States from...
Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes
WEDNESDAY, Jan. 22, 2025 -- Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict...
AI Model IDs Women With Subjective Cognitive Decline During Menopause
WEDNESDAY, Jan. 22, 2025 -- Machine learning models may be able to identify women with severe subjective cognitive decline (SCD) during the menopause...
ART Pregnancies Have Higher Exposure to Teratogenic Medications
WEDNESDAY, Jan. 22, 2025 -- Pregnancies resulting from assisted reproductive technology (ART) have a higher prevalence of exposure to teratogenic medicines...
Study IDs Signs of Topical Steroid Withdrawal in Atopic Dermatitis
WEDNESDAY, Jan. 22, 2025 -- Self-reported manifestations of topical steroid withdrawal (TSW) in atopic dermatitis (AD) include erythema, desquamation, dryness...
Spravato (esketamine) Approved in the U.S. as the First and Only Monotherapy for Adults with Treatment-Resistant Depression
Titusville, New Jersey, January 21, 2025 – Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a...
FDA Approves Datroway (datopotamab deruxtecan-dlnk) for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
WILMINGTON, Del.-- January 17, 2025 -- Datroway (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with unresectable...
Arrowhead Pharmaceuticals Announces Acceptance of New Drug Application by U.S. FDA of Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
PASADENA, Calif.–(BUSINESS WIRE)–Jan. 17, 2025– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug...
Calquence Plus Chemoimmunotherapy Approved in the U.S. for Patients with Previously Untreated Mantle Cell Lymphoma
17 January 2025 -- AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment...
FDA Approves Lumakras (sotorasib) in Combination with Vectibix (panitumumab) for Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer
THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Lumakras...
Atara Biotherapeutics Provides Regulatory and Business Update on Ebvallo (tabelecleucel)
THOUSAND OAKS, Calif.--(BUSINESS WIRE) January 16, 2025 -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel...
U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application
SHANGHAI, Jan. 7, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and...
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based...
Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
BOSTON--(BUSINESS WIRE)--Dec. 30, 2024-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with...
Dyne Therapeutics Receives FDA Fast Track Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1
WALTHAM, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing...
Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
CAMBRIDGE, Mass.-- January 21, 2025 (BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today...
Boehringer Provides Update on Iclepertin Phase III Program in Schizophrenia
Ingelheim, Germany, January 16, 2025 - Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment...
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - January 13, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to...
Datopotamab Deruxtecan Granted Priority Review in the US for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
13 January 2025 -- AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted and...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.